Skip to content

Public FDA record

Z-1512-2022: HeartWare Ventricular Assist Device (HVAD) System Batteries, Product Number 1650DE

Recall record Z-1512-2022 for Heartware, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1512-2022
Company in FDA record
Heartware, Inc.
FDA classification date
Aug 18, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Battery performance issues. Battery electrical faults render it unable to power the controller, unable to accept charge from the battery charger, and/or result in the battery to appear to remain charged while discharging.

Source facts

Action
Medtronic (Heartware) issued a Medical Device Correction notice on 06/28/2022 by letter. The notice, addressed to the VAD Coordinators, explained the issues and provided the following recommendations: 1. Please remind your patients to always keep two sources of power connected to their controller and have fully charged spare batteries available at all times. 2. Remind patients to acknowledge and report alarms. 3. Follow the Instructions for Use (IFU) for proper power source management. 4. Inform patients to be vigilant if the battery indicator lights do not decrease over time while the battery is in use. Customer Actions: Complete the enclosed Customer Confirmation Form please return the form to rs.cfqfca@medtronic.com. Please share this letter with all those who need to be aware within your organization or to any organization where patients have been transferred. UPDATE: Medtronic/Heartware issued an Urgent Medical Device notice to its consignees on 05/31/2023 via UPS 2nd day delivery. The notice is a follow-up to Medtronic's existing June 2022 customer notification letter titled "Urgent Medical Device Correction". The notice explained the issue, risk, and announced that Medtronic will begin all batteries for the new batteries with the change to the battery configuration mode. For questions regarding this communication, please contact your local Medtronic Field Representative. Medtronic Patient Services is available to assist patients at 800-635-3930 (Monday-Friday, 8 a.m.-5 p.m. Central Time). For any additional questions you can reach out to the Medtronic Office of Medical Affairs at rs.mcsmedicalaffairs@medtronic.com.
Initiated
2022-06-28
Root cause
Device Design
Distribution
Worldwide distribution. US nationwide, Japan, Indonesia, Brazil, Chile, Belgium, Italy, Germany, Switzerland, United Kingdom, Poland, Hungary, Czech Republic, Mauritius, France, South Africa, Greece, Netherlands, Sweden, Norway, Denmark, Estonia, Lebanon, Croatia, Spain, Austria, United Arab Emirates, Luxembourg, Canada, Korea, Republic Of, Israel, Qatar, India, Australia, New Zealand, Taiwan, Malaysia, Hong Kong, Singapore, Latvia, Saudi Arabia, Slovakia, North Macedonia, Finland, Turkey, Armenia, Colombia, Kazakhstan, Kuwait, Serbia, Bahrain, Egypt, Pakistan, and Ukraine.
Recall number
Z-1512-2022
Recall status
Open, Classified
CDRH record ID
194976
FDA classified
2022-08-18
Recall event number
90593

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗